Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer

NCT02270372 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Carcinoma
Advanced Ovarian Carcinoma

Interventions

BIOLOGICAL: ONT-10, Varlilumab combination

Sponsor

Cascadian Therapeutics Inc.

Collaborators

[object Object]